Posted by Michael Wonder on 29 Nov 2023
Japan's Ministry of Health, Labour and Welfare approves CSL and Arcturus Therapeutics' ARCT-154, the first self-amplifying mRNA vaccine approved for COVID in adults
27 November 2023 - Exclusive Partner in Japan, Meiji Seika Pharma advances regulatory approval.
CSL and Arcturus Therapeutics today announced that Japan's Ministry of Health, Labor and Welfare granted approval for ARCT-154, a self-amplifying mRNA (sa-mRNA) COVID-19 vaccine for initial vaccination and booster for adults 18 years and older.
